Cervical cancer is one of the most common types of human papillomavirus (HPV) associated cancers diagnosed in Canada. There has been a significant decrease in the number of women diagnosed with cervical cancer (26% decline over the last 30 years) due to widespread cervical cancer screening and HPV detection. The numbers to-date confirm the positive effect of cytology testing in screening for cervical cancer but also the need for continued screening.
The fundamental goal of cervical cancer screening and HPV-associated cytology testing is to prevent morbidity and mortality from cervical cancer. Understanding the link between HPV and cancer has changed how this type of cancer is detected. In fact, deaths from cervical cancer in Canada and the U.S. have declined by about 2% a year due to the widespread use of cytology testing. This program examines the role of HPV testing in cervical cancer and particularly in women 30 years of age and over.
This Self-Learning program has been certified by the College of Family Physicians of Canada for up to 1 Mainpro+ Credit(s). Cert+ Program ID#: 189239
Daniel Ngui (BSc, PT, MD, FCFP), Jeff Habert (MD, CCFP, FCFP), Mona Kamel (MD, BCh, FRCPC), Pravinsagar Mehta (MD, CCFP, FCFP)
Upon completion of this program, participants will be able to:
- Navigate the challenges of managing testosterone deficiency syndrome (TDS) in primary care.
- Differentiate treatment modalities in individualizing treatment of TDS.
- Effectively counsel patients to overcome barriers to treatment adherence in TDS.